Council for Innovation Promotion

C4IP accomplished a lot during the month of March! Here’s a roundup of what our Coalition has been up to over the past month. March Highlights: Promoting Patent Eligibility Reform The Patent Eligibility Restoration Act (PERA), reintroduced by Senators Thom Tillis and Chris Coons in June, remains under consideration by the 118th Congress. This important bill would resolve the […]

Strong, consistent IP protections throughout U.S. history enabled the creation of the innovative and useful technologies that we use regularly today. From clothing to transportation, every aspect of our lives has benefited greatly from IP, as shown by these historical examples from the month of March: 1917: On March 20, Gideon Sundback received a patent for a “separable fastener” — known

This chaotic area of law harms American innovation and competitiveness Without Congressional consideration or endorsement, the Supreme Court has fundamentally altered the U.S. patent system by deciding that certain categories of innovation should not receive patents by widening the “judicial exceptions” to what is eligible to be patented under 35 U.S.C. § 101. Starting in

C4IP Co-Chairs and former USPTO Directors David Kappos and Andrei Iancu just published a new opinion piece in The Hill, which draws from C4IP’s newly released Congressional Innovation Scorecard to explain how the U.S. can fix the growing disparity between its R&D spending and China’s. The scorecard found that a supermajority of Congress — nearly

America’s strong intellectual property system played a pivotal role in the rapid global response to the COVID-19 pandemic. Patents provided crucial incentives for the development of life-saving vaccines, therapies, and diagnostic tests, all of which were distributed globally. However, despite these successes, there are ongoing efforts by certain global leaders to pursue an international agreement at the World Health Organization (WHO) that would erode